Effects of Verapamil on Doxorubicin-Induced Mortality and Electrolyte Changes in the Mouse Heart

References

• Di Marco A., Gaetani M., Scarpinato B. Adriamycin (NSC-123, 127): A new antibiotic with antitumor activity. Cancer Chemotherapy Reports (1969); 53: 33–37
   PubMedGoogle Scholar
• Carter S. K. Adriamycin (NSC-123127)— thoughts for the future. Cancer Chemotherapy Reports (1975); 6: 389–397
   Google Scholar
• Davis H. L., Davis T. E. Daunorubicin and Adriamycin in cancer treatment: an analysis of their roles and limitations. Cancer Treatment Reports (1979); 63: 809–815
   PubMedGoogle Scholar
• Carter S. K. Adriamycin and related analogues. Advances in Cancer Chemotherapy, S. K. Carter, A. Golden, K. Kuretani, G. Mathe, S. Sakurai, S. Tsukagoshi, R. Umezawa. Japan Scientific Societies Press, Tokyo (1978); 71–82
   Google Scholar
• Le Frak E. A., Pitha J., Rosenheim S., Gottleib J. A. A clinicopathologic analysis of Adriamycin cardiotoxicity. Cancer (1973); 32: 302–314
   PubMed Web of Science ®Google Scholar
• Young R. C., Ozols R. P., Myers C. E. The anthracycline antineoplastic drugs. N. Engl. J. Med. (1981); 305: 139–153
   PubMed Web of Science ®Google Scholar
• Moore L., Bandon E. J., Cooney D. A. Inhibition of the cardiac mitochondrial calcium pump by Adriamycin in vitro. Biochem. Med. (1977); 18: 131–138
   PubMed Web of Science ®Google Scholar
• Olson H. M., Young D. M., Prieur D. J., Le Roy A. F., Reagan R. L. Electrolyte and morphologic alterations of myocardium in Adriamycin-treated rabbits. Am. J. Pathol. (1974); 77: 439–450
   PubMed Web of Science ®Google Scholar
• Revis N. W., Marusic N. Sequestration of 45ca2+ by mitochondria from rabbit heart, liver and kidney after doxorubicin or digoxin/doxorubicin treatment. Exp. Mol. Pathol. (1979); 31: 440–451
   PubMed Web of Science ®Google Scholar
• Dasdia T., Di Marco A., Goffredi M., Minghetti A., Necco A. Ion level and calcium fluxes in Hela cells after Adriamycin treatment. Pharmacol. Res. Commun. (1979); 11: 19–29
   PubMedGoogle Scholar
• Villani F., Piccinini F., Merelli P., Favalli L. Influence of Adriamycin on calcium exchange ability in cardiac muscle and its modification by ouabain. Biochem. Pharmacol. (1978); 27: 985–987
   PubMed Web of Science ®Google Scholar
• Fleckenstein A. Specific inhibitors and promotors of calcium action in the excitation-contration coupling of heart muscle and their role in the prevention or production of myocardial lesions. Calcium and the Heart, P. Harris, L. Opie. Acad. Press, NY (1970); 135–188
   Google Scholar
• Shigenobu K., Schnider J. A., Sperelakis N. Verapamil blockade of slow Na+ and Ca++ responses in myocardial cells. J. Pharmacol. Exp. Ther. (1974); 190: 280–288
   PubMed Web of Science ®Google Scholar
• De Boer L. W. V., Strauss H. W., Kloner R. A., et al. Autoradiographic method for measuring the ischemic myocardium at risk: effect of verapamil on infarct size after experimental coronary occlusion. Proc. Natl. Acad. Sci. USA (1980); 77: 6119–6123
   PubMed Web of Science ®Google Scholar
• Devereux D. F., Thibault L. E., Boretos J., Brennan M. F. The quantitative and qualitative impairment of wound healing by Adriamycin. Cancer (1979); 43: 932–938
   PubMed Web of Science ®Google Scholar
• Devereux D. F., Triche T. J., Webber B. L., Thibault L. E., Brennan M. F. A study of Adriamycin—reduced wound breaking strength in rats. Cancer (1980); 45: 2811–2815
   PubMed Web of Science ®Google Scholar
• Fairhurst A. S., Whittaker M. L., Ehlert F. J. Interactions of D600 (methoxyverapamil) and local anesthetics with rat brain a-adrenergic and muscarinic receptors. Biochem. Pharmacol. (1980); 29: 155–162
   PubMed Web of Science ®Google Scholar
• Hearse D. J., Baker J. E., Humphrey S. M. Verapamil and the calcium paradox. J. Mol. Cell. Cardiol. (1980); 12: 733–739
   PubMed Web of Science ®Google Scholar
• Rothschuh K. E. Concerning a process of progressive structural disorganization by injured skeletal muscle fibers. Pflugers Archiv. fur die Gesamte Physiologie des Menschen und der Tiere (1955); 260: 437–447
   Google Scholar
• Jasmin G., Bajusz E. Prevention of myocardial degeneration in hamsters with hereditary cardiomyopathy. Recent Advances in Studies on Cardiac Structure and Metabolism, A. Fleckenstein, G. Rona. University Park Press, Baltimore (1975); Vol. 6: 219–229
   Google Scholar
• Wrogemann K., Blanchaer M. C., Thakar J. H., Mezon B. J. On the role of mitochondria in the hereditary cardiomyopathy of the Syrian hamster. Recent Advances in Studies on Cardiac Structure and Metabolism, A. Fleckenstein, G. Rona. University Park Press, Baltimore (1975); Vol. 6: 231–241
   Google Scholar
• Jennings R. B., Sommers H. M., Kaltenbach J. P., West J. J. Electrolyte alterations in acute myocardial injury. Circ. Res. (1964); 14: 260–269
   PubMed Web of Science ®Google Scholar
• Bloom S., Davis D. L. Calcium as mediator of isoproterenol-induced myocardial necrosis. Am. J. Pathol. (1972); 69: 459–470
   PubMed Web of Science ®Google Scholar
• Chappel Rona C. I., Balazs G. T., Gaudry R. Comparison of cardiotoxic actions of certain sympathomimetic amines. Canad. J. Biochem. Physiol. (1959); 37: 35–52
   PubMedGoogle Scholar
• Lehr D., Krukowski M., Colon R. Correlation of myocardial and renal necrosis with tissue electrolyte changes. J. Am. Med. Assoc. (1966); 197: 145–152
   Web of Science ®Google Scholar
• Rona G., Chappel C. I., Kahn D. S. The significance of factors modifying the development of isoproterenol-induced myocardial necrosis. Am. Heart J. (1963); 66: 389–395
   PubMed Web of Science ®Google Scholar
• Schanne F. A. X., Kane A. B., Young E. E., Farber J. L. Calcium dependence of toxic cell death: a final common pathway. Sci. (1979); 206: 700–702
   PubMed Web of Science ®Google Scholar
• Suzuki T., Kanda H., Kawai Y., Tominaga K., Murata K. Cardio-toxicity of anthracycline antineoplastic drugs—clinicopathological and experimental studies. Jap. Circ. J. (1979); 43: 1000–1008
   PubMedGoogle Scholar
• Olson H. M., Capen C. C. Chronic cardiotoxicity of doxorubicin (Adriamycin) in the rat: morphologic and biochemical investigations. Toxicol. Appl. Pharmacol. (1978); 44: 605–616
   PubMed Web of Science ®Google Scholar
• Olson H. M., Capen C. C. Subacute cardiotoxicity of Adriamycin in the rat. Biochemical and ultrastructural investigations. Lab. Invest. (1977); 37: 386–394
   PubMed Web of Science ®Google Scholar
• Giri S. N., Marafino B. J., Jr. Effects of feed pairing and different doses of doxorubicin on mortality and electrolyte changes in the mouse heart. Drug. Chem. Toxicol. (1984); 7: 193–212
   PubMed Web of Science ®Google Scholar
• Singh B. N., Ellrodt G., Peter C. T. Verapamil: a review of its pharmacological properties and therapeutic use. Drugs (1978); 15: 169–197
   PubMed Web of Science ®Google Scholar
• Zelis R., Flaim S. F. “Calcium influx blockers” and vascular smooth muscle: do we really understand the mechanism. Ann. Inter. Med. (1981); 96: 124–126
   Google Scholar
• Fleckenstein A., Janke J., Doring H. J., Pachinger O. Calcium overload as the determinant factor in the production of catecholamine-induced myocardial lesions. Recent Advances in Studies on Cardiac Structure and Metabolism, E. Bajusz, G. Rona. University Park Press, Baltimore (1973); Vol. 2: 455–466
   Google Scholar
• Fleckenstein A., Janke J., Doring H. J., Leder O. Role of calcium in the production of noncoronarogenic myocardial necroses. Recent Advances in Studies on Cardiac Structure and Metabolism, A. Fleckenstein, G. Rona. University Park Press, Baltimore (1975); Vol. 6: 21–32
   Google Scholar
• Sigel H., Janke J., Fleckenstein A. Restriction of isoproterenol-induced myocardial Ca2+ uptake and necrotization in rats by a new Ca-antagonistic compound (ethy1 1–4-(3,4,5-trimethoxycinnamoyl) piperazinyl acetate (Vascoril). Recent Advances in Studies on Cardiac Structure and Metabolism, A. Fleckenstein, G. Rona. University Park Press, Baltimore (1975); Vol. 6: 121–126
   Google Scholar
• Steen E., Woolf N., Powell T., Rowles P. M. The effect of a calcium antagonist (D600) on isoprenaline-induced myocardial necrosis in the rat. Brit. J. Exp. Pathol. (1979); 60: 335–339
   PubMed Web of Science ®Google Scholar
• Young D. M., Mettler F. P., Fioravanti J. L. Adriamycin verapamil and calcium metabolism. Proc Am. Assoc. Cancer Res. (1976); 17: 90
   Web of Science ®Google Scholar
• Rabkin S. W. Interaction of external calcium concentration and verapamil on the effects of doxorubicin (Adriamycin) in the isolated heart preparation. J. Cardiovasc. Pharmacol. (1983); 5: 848–855
   PubMed Web of Science ®Google Scholar